Tempus AI vs TransMedics Group Inc — how do they compare? Tempus AI trades at $49.06 (market cap $8.69B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Tempus AI is far larger — about 3.4× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| TEM | TMDX | |
|---|---|---|
Market Cap | $8.69B | $2.54B |
Sector | Broad Market / Factor | Technology |
52-Week High | $103.25 | $150.42 |
52-Week Low | $42.37 | $61.99 |
Enterprise Value | $9.37B | $2.94B |
Trailing returns across standard periods
Latest headlines on both assets
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →